# Reverse Blood Grouping – Principle, Requirements, Procedure, Results and Limitations

&gt; Reverse blood grouping helps confirm ABO blood types. Learn its principle, tube, slide and gel methods, results chart, limitations and typing discrepancies.

Canonical URL: https://biologynotesonline.com/reverse-blood-grouping/
Author: Sourav Pan
Last updated: October 18, 2026

![Reverse Blood Grouping – Principle, Requirements, Procedure, Results and Limitations](https://biologynotesonline.com/wp-content/uploads/2024/04/reverse-blood-grouping-agglutination-principle.webp)

Reverse blood grouping is an ABO blood typing method in which the patient’s serum or plasma is tested with known A₁ and B reagent red blood cells for detection of anti-A and anti-B antibodies. It is also called serum grouping or reverse ABO typing.

Forward grouping detects A and B antigens present on the patient’s red blood cells. Reverse grouping checks the antibodies present in serum or plasma. These antibodies are usually directed against the A or B antigen absent from the person’s own red blood cells. The serum or plasma is mixed separately with known A₁ cells and B cells and the reaction is observed for hemagglutination (clumping of red blood cells).

Reverse blood grouping is performed along with forward grouping for confirmation of the ABO blood group. The reactions are compared with the forward grouping result, and any ABO discrepancy can be identified. It is commonly used in blood bank laboratories and during pre-transfusion testing.

Rh-positive or Rh-negative status is determined separately.

## What is Reverse Blood Grouping?

Reverse blood grouping is a type of blood grouping method used for detection of anti-A and anti-B antibodies present in the serum or plasma of a person using known A₁ and B reagent red blood cells. It is also referred to as serum grouping or reverse ABO typing.

The [ABO blood group system](https://biologynotesonline.com/blood-grouping-principle-and-procedure/) is based on the presence or absence of A and B antigens on red blood cells and the corresponding antibodies in the serum or plasma. These antibodies are generally found against the antigen which is absent on the person's own red blood cells. For example, blood group A usually contains anti-B antibodies in serum, while group B contains anti-A. Both antibodies are found in group O. In the case of group AB, neither of these antibodies is normally present.

Reverse blood grouping is not a separate blood group. The term "reverse blood type" refers to the blood group identified by testing the serum antibodies.

In forward grouping, the patient's red blood cells are examined for the presence of A and B antigens. The serum antibodies are tested in reverse grouping. Both methods are used together for the determination of ABO blood group. The result obtained from reverse grouping is checked against the forward grouping result. Any difference between the two results is referred to as an ABO grouping discrepancy.

## Objectives of Reverse Blood Grouping

- To detect the presence of anti-A and anti-B antibodies in the patient's serum or plasma using known A₁ and B reagent red blood cells.

- To confirm the ABO blood group obtained from forward blood grouping.

- To identify any ABO grouping discrepancy between forward and reverse grouping results, including weak, missing or unexpected serum reactions which require further investigation.

- To help prevent incorrect ABO blood grouping during pre-transfusion testing.

## Principle of Reverse Blood Grouping

![Scientific diagram showing anti-A antibodies binding to A₁ red blood cells and anti-B antibodies binding to B red blood cells, producing agglutination.](https://biologynotesonline.com/wp-content/uploads/2024/04/reverse-blood-grouping-agglutination-principle-1024x576.webp)Scientific diagram showing anti-A antibodies binding to A₁ red blood cells and anti-B antibodies binding to B red blood cells, producing agglutination.

The principle of reverse blood grouping is based on the [antigen-antibody agglutination reaction](https://biologynotesonline.com/agglutination-reaction-principle-types-mechanism-applications/) between the antibodies present in the patient's serum or plasma and the corresponding antigens on known reagent red blood cells. In this method, A₁ and B reagent red blood cells are used for detection of anti-A and anti-B antibodies.

When the patient's serum or plasma is mixed with the reagent red blood cells, the antibodies present in the serum bind to their corresponding antigens on the red blood cell surface. Anti-A antibodies react with A antigen present on A₁ cells, while anti-B antibodies react with B antigen on B cells. The antibodies join different red blood cells together forming visible clumps. This reaction is referred to as hemagglutination. The formation of clumps indicates a positive reaction. In the absence of the corresponding antibody, no agglutination occurs.

The ABO antibodies are generally found against the antigen which is absent on the person's own red blood cells. For example, a person having A antigen normally contains anti-B antibodies in the serum, whereas a person with B antigen has anti-A antibodies. Both antibodies are usually found in blood group O. In the case of group AB, neither anti-A nor anti-B is normally present.

## Requirements for Reverse Blood Grouping

- Patient Serum or Plasma- A properly collected and labelled blood sample is required for testing the ABO antibodies.

- A₁ and B Reagent Red Blood Cells- Validated red blood cell suspensions of known A₁ and B groups are used for detection of anti-A and anti-B antibodies.

- Test Tubes- Clean, labelled test tubes are used for carrying out the agglutination reactions.

- Pipettes and Tips- Used for transferring measured amounts of serum or plasma and reagent red blood cells.

- Test Tube Rack- It is used to hold the reaction tubes during the test.

- Serological Centrifuge- Used for centrifugation of the reaction mixtures in the tube method.

- Mixing Equipment- A suitable mixer or gentle manual mixing is used to mix the reaction components.

- Normal Saline- Used for preparing or washing red blood cell suspensions when required.

- Observation and Recording Materials- A suitable light source, marker and laboratory worksheet are used for observing and recording the results.

- Quality Control Materials- Appropriate controls are used to check the performance of the reagent red blood cells.

- Laboratory Procedure- An approved test procedure and manufacturer instructions are required for selecting the correct reagent concentrations and operating settings.

- Protective Equipment- Laboratory coat, disposable gloves and other required protective materials are used while handling blood samples.

## Reverse Blood Grouping Procedure

Reverse blood grouping can be performed by tube method, slide method and gel card method. Before performing the test, the patient's serum or plasma should be separated from a properly collected and labelled blood sample. The A₁ and B reagent red blood cells are checked for their quality and expiry. All the reaction vessels are labelled with the sample identification and reagent cell type.

The following are the procedures for different methods of reverse blood grouping-

![Three laboratory workflows showing reverse blood grouping by tube, slide and gel card methods, with A₁-negative and B-positive reactions for an illustrative group A serum sample.](https://biologynotesonline.com/wp-content/uploads/2024/04/reverse-blood-grouping-tube-slide-gel-methods-1024x576.webp)Three laboratory workflows showing reverse blood grouping by tube, slide and gel card methods, with A₁-negative and B-positive reactions for an illustrative group A serum sample.

### 1. Tube Method

- Take two clean test tubes and label them as A₁ and B.

- Add the required amount of patient's serum or plasma into both tubes.

- Add A₁ reagent red blood cell suspension to the A₁ tube and B reagent red blood cells to the B tube.

- Mix the contents gently and centrifuge the tubes using a serological centrifuge according to the approved laboratory settings.

- Remove the tubes and gently resuspend the red blood cell button formed at the bottom.

- Examine each tube for the presence or absence of agglutination. Any visible hemolysis should also be noted.

- Record the reaction as positive, negative or weak according to the agglutination observed. Any unexpected reaction is recorded for further investigation.

### 2. Slide Method

- Take a clean glass slide and mark two separate areas as A₁ and B.

- Place a small amount of patient's serum or plasma on each marked area.

- Add known A₁ reagent red blood cells to the first area and B cells to the second area.

- Mix the serum and reagent cells separately using clean applicator sticks.

- Gently rock the slide and observe for visible clumping of red blood cells within the specified reading time.

- Record the presence or absence of agglutination in both areas. Avoid reading dried reaction mixtures.

The slide method is mainly used for demonstration or preliminary testing. It is less sensitive for detecting weak antibodies and may give difficulty in reading weak agglutination. It is not recommended as the only method for clinical ABO confirmation.

### 3. Gel Card Method (Column Agglutination)

- Take a suitable ABO reverse grouping gel card containing neutral gel microcolumns for A₁ and B cells.

- Add the compatible A₁ and B reagent red blood cell suspensions into their respective microcolumns.

- Add the required amount of patient's serum or plasma to each microcolumn according to the manufacturer's instructions.

- Incubate the card if required by the test method and centrifuge it using a suitable gel card centrifuge.

- After centrifugation, examine the position of red blood cells in each gel column.

- Positive reaction- The agglutinated red blood cells remain trapped at the top or within the gel column.

- Negative reaction- The non-agglutinated red blood cells pass through the gel and form a button at the bottom.

- Record the reaction strength and any weak or unexpected reaction. The results are checked against the forward grouping result.

The gel card method is commonly used in standardized and automated blood grouping systems. The reagent volumes, incubation conditions and centrifugation settings depend on the validated test method and manufacturer instructions.

## Results and Interpretation of Reverse Blood Grouping

The results of reverse blood grouping are determined by observing the agglutination reaction between the patient's serum or plasma and known A₁ and B reagent red blood cells. A positive reaction indicates the presence of the corresponding ABO antibody in the serum. No agglutination indicates a negative reaction.

![Reverse blood grouping chart showing A₁ and B reagent cell agglutination patterns for blood groups A, B, AB and O, with their expected serum antibodies.](https://biologynotesonline.com/wp-content/uploads/2024/04/reverse-blood-grouping-results-chart-1024x576.webp)Reverse blood grouping chart showing A₁ and B reagent cell agglutination patterns for blood groups A, B, AB and O, with their expected serum antibodies.

Positive Reaction- The reagent red blood cells form visible clumps due to antigen-antibody reaction.

Negative Reaction- No visible clumping of red blood cells occurs.

The reaction obtained with A₁ cells indicates the presence of anti-A antibodies, while the reaction with B cells indicates anti-B antibodies.

### Reverse Blood Grouping Results Chart

ABO Blood GroupReaction with A₁ CellsReaction with B CellsAntibodies DetectedANegative (−)Positive (+)Anti-BBPositive (+)Negative (−)Anti-AABNegative (−)Negative (−)Neither anti-A nor anti-BOPositive (+)Positive (+)Both anti-A and anti-B

Positive (+) indicates agglutination and Negative (−) indicates no agglutination.

For example, if the patient's serum shows agglutination with B reagent red blood cells but not with A₁ cells, it indicates the presence of anti-B antibodies. The expected blood group is A.

These are the normal expected reactions of reverse blood grouping. The results are compared with forward blood grouping for confirmation of the ABO group. Any weak, missing or unexpected reaction is considered an ABO grouping discrepancy and requires further investigation before reporting the final blood group.

## Forward vs Reverse Blood Grouping

Forward blood grouping is used for detection of A and B antigens present on the patient's red blood cells, whereas reverse blood grouping detects anti-A and anti-B antibodies in the serum or plasma. Both methods are used for determination of the ABO blood group. The main differences between them are given below-

![Comparison of forward and reverse ABO blood grouping using a group A sample, showing patient red cell reactions with antisera and serum reactions with known A₁ and B cells.](https://biologynotesonline.com/wp-content/uploads/2024/04/forward-vs-reverse-blood-grouping-1024x576.webp)Comparison of forward and reverse ABO blood grouping using a group A sample, showing patient red cell reactions with antisera and serum reactions with known A₁ and B cells.

FeaturesForward Blood GroupingReverse Blood GroupingDefinitionIt is a method of detecting ABO antigens on red blood cells.It is a method of detecting ABO antibodies in serum or plasma.Test SpecimenPatient's red blood cells are used.Patient's serum or plasma is used.Reagents UsedKnown anti-A and anti-B antisera.Known A₁ and B reagent red blood cells.What is DetectedA and B antigens.Anti-A and anti-B antibodies.ReactionReagent antibodies react with antigens present on the patient's red blood cells.Serum antibodies react with the corresponding antigens on reagent red blood cells.Positive ResultAgglutination indicates the presence of the corresponding antigen.Agglutination indicates the presence of the corresponding antibody.InterpretationThe ABO group is determined from the antigen reaction pattern.The ABO group is identified from the expected antibody reactions.Main PurposeUsed for determining the ABO blood group from red cell antigens.Used for checking and confirming the ABO group obtained by forward grouping.

The results of forward and reverse blood grouping should agree with each other. For example, in blood group A, the red blood cells react with anti-A antiserum during forward grouping but not with anti-B. In reverse grouping, the serum reacts with B reagent red blood cells. No reaction is normally obtained with A₁ cells.

Any difference between the expected forward and reverse grouping results is referred to as an ABO grouping discrepancy. Such discrepancies are investigated before reporting the ABO blood group.

## ABO Grouping Discrepancies

ABO grouping discrepancy occurs when the results of forward and reverse blood grouping do not agree with each other. It may be caused by weak or missing antigens, antibodies, unexpected reactions or errors during blood grouping.

Some of the common causes of ABO grouping discrepancies are-

- Incorrect sample labelling, improper centrifugation, wrong reagents or errors in preparing red blood cell suspensions may produce incorrect blood grouping results.

- Weak or missing ABO antibodies are commonly observed in newborns, elderly persons and patients with immunodeficiency or receiving immunosuppressive treatment. The reverse grouping may show weak or absent agglutination.

- Weak expression of A or B antigens, particularly in ABO subgroups, may cause weak or unexpected reactions during forward blood grouping.

- Cold-reacting autoantibodies and unexpected alloantibodies may react with reagent red blood cells, producing additional agglutination during reverse grouping. Anti-A₁ antibodies can also cause discrepancies in some A subgroups.

- Increased plasma proteins in conditions such as multiple myeloma may cause rouleaux formation, where red blood cells are arranged in stacks. It may be mistaken for true agglutination.

- In patients who have received a recent blood transfusion or undergone hematopoietic stem cell transplantation, different populations of red blood cells may be present. This can produce mixed-field agglutination during blood grouping.

- Certain rare conditions such as acquired B antigen and the Bombay blood group phenotype may also produce unexpected ABO grouping reactions.

- Any discrepancy between forward and reverse grouping must be investigated before reporting the blood group. The sample identification, reagents and test procedure are checked first. Further testing may include repeating the blood grouping, antibody investigation and examination of the patient's transfusion or medical history.

## Limitations of Reverse Blood Grouping

- Reverse blood grouping is not routinely performed in infants below 4 months. The ABO antibodies are not sufficiently developed at this age.

- Weak or missing antibodies in elderly persons and patients with immunodeficiency may give weak or negative reactions.

- Cold-reacting autoantibodies and unexpected alloantibodies can cause additional agglutination during reverse grouping. Anti-A₁ antibodies in some A subgroups may also produce unexpected reactions.

- Increased plasma proteins may cause rouleaux formation. It can be mistaken for true agglutination.

- The expected ABO antibody reactions may be altered in patients who have received a recent plasma transfusion or undergone hematopoietic stem cell transplantation.

- Errors in sample identification, incorrect reagent preparation and improper centrifugation may affect the test results.

- It cannot determine the [Rh-positive or Rh-negative blood group](https://biologynotesonline.com/rh-blood-group-system/).

- Reverse blood grouping cannot be used alone for final determination of the ABO blood group. The results must be checked with forward grouping.

## Advantages of Reverse Blood Grouping

- It is used for detection of anti-A and anti-B antibodies present in the patient's serum or plasma.

- The results are compared with forward blood grouping for confirmation of the ABO blood group.

- It can identify weak, missing or unexpected antibody reactions which may indicate an ABO grouping discrepancy. These reactions can be further investigated.

- Reverse blood grouping provides an additional check during pre-transfusion testing. It helps in reducing the risk of ABO-incompatible blood transfusion.

- The test is relatively simple and can be performed using the tube method or validated gel card and automated blood grouping systems.

## Uses of Reverse Blood Grouping

- Reverse blood grouping is used for detection of anti-A and anti-B antibodies present in the patient's serum or plasma.

- It is performed along with forward blood grouping for confirmation of the ABO blood group in patients and blood donors.

- Weak, missing or unexpected antibody reactions can be identified during reverse grouping. These reactions are further investigated to detect ABO grouping discrepancies.

- In pre-transfusion testing, reverse grouping provides an additional check to reduce the risk of ABO-incompatible blood transfusion.

## Reverse Blood Grouping at a Glance

FeaturesDescriptionDefinitionA blood grouping method used to detect anti-A and anti-B antibodies in serum or plasma.Also Known AsSerum grouping or reverse ABO typing.PrincipleAntigen-antibody agglutination reaction.Test SpecimenPatient's serum or plasma.Reagents UsedKnown A₁ and B reagent red blood cells.Antibodies DetectedAnti-A and anti-B antibodies.Positive ReactionVisible agglutination of reagent red blood cells.Negative ReactionNo agglutination occurs.Blood Group AAgglutination with B cells only. Anti-B is present.Blood Group BAgglutination with A₁ cells only. Anti-A is present.Blood Group ABNo agglutination with either reagent cell. Neither antibody is normally present.Blood Group OAgglutination with both A₁ and B cells. Anti-A and anti-B are present.MethodsTube method, slide method and gel card method.Main PurposeTo confirm ABO blood group obtained from forward grouping.Clinical UseUsed in pre-transfusion testing and investigation of ABO grouping discrepancies.LimitationsWeak or missing antibodies and unexpected reactions may affect the results.InfantsNot routinely performed below 4 months of age.Rh TypingIt does not determine Rh-positive or Rh-negative status.Result ConfirmationThe result must agree with forward blood grouping.

## References

- Dean, L. (2005). Blood groups and red cell antigens. National Center for Biotechnology Information (US). [https://www.ncbi.nlm.nih.gov/books/NBK2261/](https://www.ncbi.nlm.nih.gov/books/NBK2261/)

- Desai, P., Navkudkar, A., &amp; Rajadhyaksha, S. (2024). ABO blood group discrepancies in blood donor and patient samples at a tertiary care oncology centre: Analysis and serological resolution. Hematology, Transfusion and Cell Therapy, 46(4), 402–407. [https://doi.org/10.1016/j.htct.2023.07.011](https://doi.org/10.1016/j.htct.2023.07.011)

- Jain, A., Garg, S., Marwaha, N., &amp; Sharma, R. R. (2020). ABO blood grouping discrepancies in the donor population. ISBT Science Series, 15(2), 281–285. [https://doi.org/10.1111/voxs.12550](https://doi.org/10.1111/voxs.12550)

- Makroo, R. N., Kakkar, B., Agrawal, S., Chowdhry, M., Prakash, B., &amp; Karna, P. (2019). Retrospective analysis of forward and reverse ABO typing discrepancies among patients and blood donors in a tertiary care hospital. Transfusion Medicine, 29(2), 103–109. [https://doi.org/10.1111/tme.12506](https://doi.org/10.1111/tme.12506)

- Meny, G. M. (2017). Recognizing and resolving ABO discrepancies. Immunohematology, 33(2), 76–81. [https://doi.org/10.21307/immunohematology-2019-012](https://doi.org/10.21307/immunohematology-2019-012)

- Milkins, C., Berryman, J., Cantwell, C., Elliott, C., Haggas, R., Jones, J., Rowley, M., Williams, M., &amp; Win, N. (2013). Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfusion Medicine, 23(1), 3–35. [https://doi.org/10.1111/j.1365-3148.2012.01199.x](https://doi.org/10.1111/j.1365-3148.2012.01199.x)

- Raman, L., Armstrong, B., &amp; Smart, E. (2020). Principles of laboratory techniques. ISBT Science Series, 15(S1), 81–111. [https://doi.org/10.1111/voxs.12591](https://doi.org/10.1111/voxs.12591)

- Storry, J. R., &amp; Olsson, M. L. (2009). The ABO blood group system revisited: A review and update. Immunohematology, 25(2), 48–59. [https://doi.org/10.21307/immunohematology-2019-231](https://doi.org/10.21307/immunohematology-2019-231)
